Expected Blood Pressure Reduction with Propranolol 80 mg Daily
Propranolol 80 mg daily reduces systolic blood pressure by approximately 11 mm Hg and diastolic blood pressure by approximately 9 mm Hg in patients with moderate hypertension. 1
Magnitude of Blood Pressure Reduction
In patients with normal-renin moderate hypertension, propranolol 80 mg daily produces a significant decrease of 11 ± 4 mm Hg in systolic blood pressure and 9 ± 3 mm Hg in diastolic blood pressure at rest. 1
Increasing the dose to 160 mg daily yields only modestly greater reductions (systolic 16 ± 4 mm Hg, diastolic 12 ± 3 mm Hg), with no additional benefit at doses of 320 mg or 640 mg daily. 1
The FDA-approved labeling confirms that the usual initial dose for hypertension is 80 mg once daily (extended-release formulation), with maintenance doses typically ranging from 120–160 mg daily, though some patients may require up to 640 mg. 2
Clinical Context and Dosing Considerations
The full antihypertensive response to a given dose is variable and may take from a few days to several weeks to manifest, so blood pressure should be reassessed over time rather than immediately after initiation. 2
Propranolol 80 mg daily achieves most of the drug's antihypertensive effect not only at rest but also during exercise, suggesting that relatively low doses provide near-maximal blood pressure control. 1
The 2025 ACC/AHA Hypertension Guideline recommends a target blood pressure of <130/80 mm Hg in adults at increased cardiovascular risk (defined as ≥7.5% 10-year PREVENT risk), with encouragement to achieve systolic <120 mm Hg when feasible. 3
Important Caveats
Beta-blockers are not first-line agents for uncomplicated hypertension; current guidelines favor renin-angiotensin system inhibitors, calcium-channel blockers, and thiazide-type diuretics as the preferred initial therapy. 4
Propranolol is contraindicated in patients with reactive airway disease (asthma, COPD), second- or third-degree AV block, severe bradycardia (<60 bpm), and decompensated heart failure. 5
The blood pressure reduction observed in clinical trials reflects average responses; individual variability is substantial, and some patients may experience greater or lesser effects. 1